巨噬细胞转录因子TonEBP通过损伤诱导信号通路促进系统性红斑狼疮和肾损伤
该研究探讨了TonEBP在系统性红斑狼疮(SLE)和狼疮肾炎(LN)中的作用。LN患者肾活检中TonEBP表达在肾脏细胞和浸润免疫细胞中均升高,且TonEBP mRNA与炎症细胞因子mRNA及蛋白尿程度相关。在pristane诱导的SLE小鼠模型中,髓系TonEBP缺失阻断了SLE和LN的发生。机制上,TLR通过刺激TonEBP启动子诱导其表达,TonEBP作为NF-κB的转录辅因子并通过蛋白-蛋白相互作用激活mTOR-IRF3/7;TonEBP缺陷巨噬细胞胞葬作用增强,髓系TonEBP缺陷动物Th1和Th17分化减少。作者认为髓系TonEBP可能是SLE和LN的有吸引力的治疗靶点。
要点
- LN患者肾活检中TonEBP在肾脏细胞和浸润免疫细胞中表达均升高。
- 肾脏TonEBP mRNA在LN中升高,且与炎症细胞因子mRNA及蛋白尿程度相关。
- pristane诱导SLE小鼠中髓系TonEBP缺失阻断SLE和LN发生。
核心结论
- 髓系TonEBP可能是SLE和LN有吸引力的治疗靶点。
研究设计与样本
- 研究检测了LN患者肾活检样本中TonEBP的表达,并在pristane诱导的SLE小鼠模型中通过髓系TonEBP缺失进行评估。
主要发现
- LN患者肾活检中肾脏TonEBP表达在肾脏细胞和浸润免疫细胞中均较对照患者升高。
- 肾脏TonEBP mRNA在LN中升高,并与编码炎症细胞因子的mRNA及蛋白尿程度相关。
- pristane诱导SLE小鼠中髓系TonEBP缺失阻断了SLE和LN的发生。
- 巨噬细胞中多种识别损伤相关分子模式的Toll样受体(TLR)参与通过刺激TonEBP启动子诱导TonEBP表达。
- TonEBP缺陷巨噬细胞显示胞葬作用增强,髓系TonEBP缺陷动物Th1和Th17分化减少。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Systemic lupus erythematosus (SLE) is an autoimmune disorder characterized by autoreactive B cells and dysregulation of many other types of immune cells including myeloid cells. Lupus nephritis (LN) is a common target organ manifestations of SLE. Tonicity-responsive enhancer-binding protein (TonEBP, also known as nuclear factor of activated T-cells 5 (NFAT5)), was initially identified as a central regulator of cellular responses to hypertonic stress and is a pleiotropic stress protein involved in a variety of immunometabolic diseases. To explore the role of TonEBP, we examined kidney biopsy samples from patients with LN. Kidney TonEBP expression was found to be elevated in these patients compared to control patients - in both kidney cells and infiltrating immune cells. Kidney TonEBP mRNA was elevated in LN and correlated with mRNAs encoding inflammatory cytokines and the degree of proteinuria. In a pristane-induced SLE model in mice, myeloid TonEBP deficiency blocked the development of SLE and LN. In macrophages, engagement of various toll-like receptors (TLRs) that respond to damage-associated molecular patterns induced TonEBP expression via stimulation of its promoter. Intracellular signaling downstream of the TLRs was dependent on TonEBP. Therefore, TonEBP can act as a transcriptional cofactor for NF-κB, and activated mTOR-IRF3/7 via protein-protein interactions. Additionally, TonEBP-deficient macrophages displayed elevated efferocytosis and animals with myeloid deficiency of TonEBP showed reduced Th1 and Th17 differentiation, consistent with macrophages defective in TLR signaling. Thus, our data show that myeloid TonEBP may be an attractive therapeutic target for SLE and LN.
引用
- Yoo EJ, Oh KH, Piao H, et al. Macrophage transcription factor TonEBP promotes systemic lupus erythematosus and kidney injury via damage-induced signaling pathways. Kidney Int. 2023. PMID: 37088425. doi:10.1016/j.kint.2023.03.030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。